IDEAYA Biosciences, Inc. — Investor Relations & Filings
Filings indexed
465
across all filing types
Latest filing
2026-06-01
Regulatory Filings
Country
US
United States of America
Listing
US
IDYA
IDEAYA Biosciences, Inc. is a clinical-stage precision medicine oncology company focused on the discovery, development, and commercialization of targeted therapeutics for cancer. The company's primary scientific approach is synthetic lethality, an emerging class of precision medicine that targets cancer cells based on specific genetic alterations. IDEAYA develops potential first-in-class and best-in-class therapies for patient populations selected using molecular diagnostics. Its integrated platform combines capabilities in target and biomarker discovery with the development of small molecule and protein degrader therapeutics to address unmet needs in cancer treatment.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-06-01 | English | |
| S-3ASR - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-05-05 | English | |
| 8-K - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-05-05 | English | |
| 8-K - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-04-13 | English | |
| 8-K - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-04-09 | English | |
| SCHEDULE 13G/A - IDEAYA Biosciences, Inc. (0001676725) (Subject) | 2026-03-27 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47923319 | 8-K | 2026-06-01 | English | ||
| 41528732 | S-3ASR - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-05-05 | English | ||
| 41325620 | 8-K - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-05-05 | English | ||
| 34403025 | 8-K - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-04-13 | English | ||
| 33898483 | 8-K - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-04-09 | English | ||
| 33061067 | SCHEDULE 13G/A - IDEAYA Biosciences, Inc. (0001676725) (Subject) | 2026-03-27 | English | ||
| 32896471 | 4 - IDEAYA BIOSCIENCES, INC. (0001676725) (Filer) | 2026-03-03 | English | ||
| 32896472 | 8-K - IDEAYA BIOSCIENCES, INC. (0001676725) (Filer) | 2026-02-17 | English | ||
| 31258355 | 10-K Filing | 2026-02-17 | English | ||
| 31258163 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 19424576 | SCHEDULE 13G/A - IDEAYA Biosciences, Inc. (0001676725) (Subject) | 2026-02-12 | English | ||
| 31258199 | 4 Filing | 2026-02-02 | English | ||
| 31258190 | 4 Filing | 2026-02-02 | English | ||
| 31258189 | 4 Filing | 2026-02-02 | English | ||
| 31258159 | 4 Filing | 2026-02-02 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
IDEAYA Biosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31547/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31547 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31547 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31547 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31547}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IDEAYA Biosciences, Inc. (id: 31547)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.